🔗 Share this article

A shadow market for unlicensed slimming drugs is being driven by TikTok fitness influencers and vendors on communication apps, according to new investigations.

Experimental Drug Acquiring Popularity Via Social Media

The experimental drug, which is still in research studies, is being advertised by online personalities for its alleged weight-reducing properties. Followers are urged to message these accounts privately for supplier links, while also receiving discount codes.

Thriving Trade on Messaging Platforms

Additionally, a robust trade exists on messaging services, where groups with thousands of participants share comparison images, injection guides and claims of next-day UK delivery. Sellers promote the substance there before redirecting customers to WhatsApp for transactions.

Learning About Retatrutide

This medication is an experimental injectable developed by American pharmaceutical company Eli Lilly. The drug affects three intestinal hormones – glucagon-like peptide-1, GIP and glucagon. Early trials indicate it could assist patients lose up to 25% of their body weight. Referred to as the “triple G”, the drug is being hailed digitally as the next Ozempic.

Healthcare Professionals Voice Concerns

However, physicians and pharmacists have warned that the distribution of what remains an unlicensed drug in the United Kingdom is worrisome and could result in users administering products of unknown origin.

Some experts said the demand for retatrutide could be linked to the increasing price of approved weight loss products such as Mounjaro.

Legal Position and Enforcement

Selling retatrutide on social media or Telegram is prohibited in the United Kingdom, as it is an unlicensed drug that must not be marketed or supplied for personal consumption under the British medical regulations.

Some content creators attempt to sidestep the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted drug, but promotion and supply can still breach pharmaceutical, advertising, and customer regulations, potentially leading to fines, prosecution or prison.

Service Response and Material Elimination

Based on TikTok, the service has taken down violative material and prohibited associated hashtags and search suggestions. The company said it was committed to keeping the service safe and allocating resources in enhancing compliance measures.

Digital Trading Operations

Investigations also discovered groups with up to 9,000 members selling the experimental drug using the platform's integrated search feature, which functions like a public directory. Typing “retatrutide” immediately brings up channels with thousands of members, filled with images of slimming results, positive testimonials and step-by-step guides for mixing or administering at home.

After minutes of entering one community, a seller posted WhatsApp details, where the majority of transactions take place. The seller sent an instruction manual and promised delivery within two days. When asked whether the product was genuine, one vendor said: “You can’t be sure.” Another provided a photo of a alleged laboratory certificate. Not one inquired about body mass, medical conditions or past usage.

Item Information and Pricing

Inside these groups, posts display dark colored packages with postal service stickers, stating to contain fresh supplies. One message stated: “It took eight of us to load them this morning.”

Customers can choose between dry substance containers, mixed at residence with sterile water, or ready-to-use pens usually sold at 160 pounds for 20mg. When questioned how much time a injector should last, sellers give contradictory answers varying between a several days to “depends on your body”.

Service Oversight and Safety Measures

A representative for Telegram stated it actively monitored dangerous material on its platform including material that encouraged the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.

Medical Expert Cautions

“People are injecting materials they can’t verify. Although the science behind this drug is valid, these digital versions may not contain what they claim,” said a pharmacy expert, the head of pharmacy at a pharmacy service.

A medical professional of Asda Online Doctor connected the surge in interest to recent price rises for authorized weight-loss drugs such as Mounjaro. “With prices increasing, individuals are using social media. But counterfeit injections are highly risky. You cannot know what’s inside or whether the environment they were produced in was clean,” she explained.

Her staff has already seen patients injured by self-injection from unverified suppliers. “We recognize the disappointment, but purchasing from messaging apps or WhatsApp is gambling with your health,” stated the doctor. “These materials could be contaminated or incorrectly dosed.”

Producer Position

A spokesperson from the pharmaceutical company said the substance was in third stage clinical trials and had not been evaluated or authorized by any government authority anywhere in the world. “Consequently at this time no one can market [it] for human use,” they explained, adding that any item “misleadingly claiming itself as a Lilly experimental substance not yet approved … may subject users to possibly significant health risks”.